Results 61 to 70 of about 2,128 (205)
Comprehensive management of vulvovaginal cancers
Abstract Vulvar and vaginal cancers represent rare malignancies, with an incidence of 2.7 per 100,000 women for vulvar cancer, predominantly affecting women older than 60 years, although rising rates are observed in younger demographics. Approximately 90% of vulvar cancers are squamous cell carcinoma and frequently are associated with human ...
Angélica Nogueira‐Rodrigues +5 more
wiley +1 more source
Pink Polypoid Papulo‐Vesicles on Labia Majora
JEADV Clinical Practice, EarlyView.
Maria Chiara Mercuri +3 more
wiley +1 more source
Cancer of the vulva: 2025 update
Abstract Vulvar cancer is an uncommon gynecological malignancy primarily affecting postmenopausal women. No specific screening exists and the most effective strategy to reduce the incidence of vulvar cancer is the opportune treatment of predisposing and preneoplastic lesions associated with its development.
Alexander B. Olawaiye +3 more
wiley +1 more source
Infectious Morbidity After Radical Vulvectomy [PDF]
Objective: This retrospective investigation describes the infectious morbidity of patients following radical vulvectomy with or without inguinal lymph node dissection.Methods: The charts of patients undergoing radical vulvectomy between January 1, 1986, and September 1, 1989, were reviewed for age, weight, cancer type, tumor stage, operative procedure ...
Elg, Steven A. +4 more
openaire +2 more sources
Objectives: Due to low incidence of vulvar cancer (VC), incidence and predictors for development of venous thromboembolism (VTE) are poorly understood.
Quinn Kistenfeger +5 more
doaj +1 more source
Abstract Background In Botswana, a multidisciplinary team (MDT) clinic was established in 2015 to streamline care for all patients with gynecological malignancies including cervical cancer, Botswana’s leading cause of cancer mortality. Methods Patients presenting at the MDT clinic in Gaborone, Botswana, were prospectively enrolled.
Emily MacDuffie +16 more
wiley +1 more source
ABSTRACT Purpose Systemic treatment options for vulvar squamous cell carcinoma (VSCC) are limited. ROS1, a tyrosine kinase implicated, for example, in non‐small cell lung cancer (NSCLC), has recently shown responsiveness to tyrosine kinase inhibitors.
Meletios P. Nigdelis +10 more
wiley +1 more source
Complications which were related either to radical vulvectomy or to lymphadenectomy have mostly developed in post operative period. Here, we report an intra-operative cardiac arrest case during radical vulvectomy which is under combined spinal and ...
Tayfun Gungor¹ +5 more
core
Abstract Objectives To compare topical imiquimod with CO2 laser therapy for the treatment of a first episode of vulvar high‐grade squamous intraepithelial lesions (vHSIL), to identify serious adverse effects of both treatment modalities, and to examine risk factors for treatment failure.
Elizabeth Svoboda +9 more
wiley +1 more source
A considerable proportion of vulvar cancer survivors experienced persistent functional impairments, even more than 5 years posttreatment. Additionally, they reported more vulvar symptoms and sexual dysfunction compared to women from a normative population sample.
Christin Julia Meltzer‐Gunnes +4 more
wiley +1 more source

